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ABSTRACT: Micropenis refers to a normally structured penis, 
which is abnormally small, with a stretched length of less than 
2.5 standard deviations (SD) below the mean of age or stage of 
sexual development. Patients with true micropenis usually have 
a 46,XY karyotype, associated to normally located male gonads, 
without any sign of other penile malformations. Penile length is 
measured from the point where the penis meets the pubic bone 
to the distal tip of the glans on maximal stretch, compressing 
any fat over suprapubic area. Differential diagnosis include 
buried penis (inability to adequately expose the penis, due to 
a severe phymosis associated to a decreased length of penile 
skin, which retain the shaft inside the preputial cavity), and 
obesity with excess fat pad over supra pubic area. The causes 
of congenital or true micropenis can be divided into three 
major groups: hypogonadotropic hypogonadism (pituitary/
hypothalamic failure), hypergonadotropic hypogonadism 
(primary testicular failure) and idiopathic (associated with a 
functional hypothalamus–pituitary–testicular axis). Clinical 
treatment is based on testosterone therapy. Surgical treatment 
options are used after failed penile enlargement with testosterone 
therapy and include penile elongation, suprapubic fat pad 
aspiration and eventually neophaloplasty.
Keywords: Penis/abnormalities; Penis/pathology; Penis/
physiopathology; Urology; Pediatrics; Endocrinology.
RESUMO: Micropênis refere-se a um pênis normalmente 
formado, anormalmente pequeno, com um comprimento inferior 
a 2,5 desvios-padrão (DP) abaixo da média da idade ou do estágio 
de desenvolvimento sexual. Pacientes com micropênis verdadeiro 
geralmente apresentam  cariótipo 46, XY, associado a gônadas 
masculinas normalmente localizadas, sem qualquer sinal de outras 
malformações penianas. O comprimento do pênis é medido a 
partir do ponto onde o pênis encontra o osso púbico até a ponta 
distal da glande no alongamento máximo, comprimindo qualquer 
gordura sobre a área suprapúbica. O diagnóstico diferencial 
inclui buried penis - penis embutido (incapacidade de expor 
adequadamente o pênis, devido a uma severa estomia associada 
à diminuição do comprimento da pele do pênis, que retém o 
eixo dentro da cavidade prepucial) e obesidade com excesso 
de gordura na região supra púbica. As causas do micropênis 
congênito ou verdadeiro podem ser divididas em três grandes 
grupos: hipogonadismo hipogonadotrófico (falência hipofisária / 
hipotalâmica), hipogonadismo hipergonadotrófico (insuficiência 
testicular primária) e idiopático (associado a um eixo hipotálamo-
hipófise-testicular funcional). O tratamento clínico é baseado 
na terapia com testosterona. As opções de tratamento cirúrgico 
são usadas após falha do aumento do pênis com terapia de 
testosterona e incluem alongamento do pênis, aspiração de gordura 
suprapúbica e, eventualmente, neofaloplastia.
Descritores: Pênis/anormalidades; Pênis/patologia; Pênis/
fisiopatologia; Urologia; Pediatria; Endocrinologia.
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INTRODUCTION
Micropenis refers to a normally structured penis, which is abnormally small, with a 
stretched length of less than 2.5 standard deviations (SD) 
below the mean of age or stage of sexual development1 
(Figure. 1). Micropenis may occur as an independent 
abnormality by itself or as a clinical finding with many 
syndromes. The reported incidence of true micropenis was 
reported to be 1.5 in 10,000 male children born between 
1997 and 20002. Patients with true micropenis usually have 
a 46,XY karyotype, associated to normally located male 
gonads, without any sign of other penile malformations, 
such as hypospadias3 (Figure 2).
Figure 1 - Habitus in a 10-year-old boy with micropenis
Figure 2 - Testes and urethra are topic
Normal Development
Normal development of male genitalia is a 
complex process that includes fetal gonadal stimulation 
by the placental Human Chorionic Gonadotrophin 
(hCG) starting at fifth week of gestation, leading to the 
production of Mullerian Inhibitory Substance (MIS) and 
5-α-dihydrotestosterone (DHT), which are required for 
the development of male internal genital structures and 
differentiation of male external genitalia4. After eight weeks 
of gestation, testosterone itself begins to be produced and 
stimulates the intra-utero penile growth. 
Without satisfactory hypothalamic or pituitary 
function, inadequate growth will occur despite a normal 
shaped penis. Similarly, a primary testicular disorder that 
causes insufficient testosterone production near the end of 
gestation also can result in minimal penile growth5.
Adequate Measurement and Diagnostic criteria 
To prevent confounding diagnoses, the examining 
clinician must have a clear understanding of definition of 
micropenis. Penile length is measured from the point where 
the penis meets the pubic bone to the distal tip of the glans 
on maximal stretch, compressing any fat over suprapubic 
area6 (Figure 3). 
Figure 3 - Adequate measurement of penile length: note the 
depressed prepubic fat by the ruler, placed upon the pubic bone
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Important to note that as the child body grows in a 
constant fashion until puberty, the penile growth is induced 
mostly by testosterone action7. As a result, immediately 
before puberty, children commonly have a large size 
disproportion between the penis and the rest of the body, 
causing anxiety and confusing parents about penile size. 
Table 1 shows the penile length and the standard deviation 
according to age. As stated before, micropenis is defined 
when the penile length is below 2.5 standard deviations 
when adequately measured.
Table 1 - Stretched penile length (in centimeters) by age
Age Mean ± SD
Newborn (30 weeks)* 2.5 ± 0.4
Newborn (term)* 3.5 ± 0.4
0 to 5 months† 3.9 ± 0.8
6 to 12 months† 4.3 ± 0.8
1 to 2 years† 4.7 ± 0.8
2 to 3 years† 5.1 ± 0.9
3 to 4 years† 5.5 ± 0.9
5 to 6 years† 6.0 ± 0.9
10 to 11 years† 6.4 ± 1.1
Adult‡ 12.4 ± 2.7
†Source: Schonfeld and Beebe (Feldman K. 1975;86:395-8).
‡Source: Wessells et al. (Schonfeld W, 1942).
*Source: Feldman and Smith (Wessells H, 1996).
Differential diagnoses 
A) Buried penis
Buried Penis (BP) is an uncommon anomaly first 
described by Keyes in 1919 as “an apparent absence of 
the penis which occurs when it lacks its proper sheath 
of skin and lies buried beneath the integument of the 
abdomen, suprapubic fat or scrotum” (Figure 4). It is 
caused by the inability to adequately expose the penis, 
due to a severe phymosis associated to a decreased length 
of penile skin, which retain the shaft inside the preputial 
cavity, sometimes precluding adequate measurement of its 
length. Other terms used to describe the situation include 
concealed penis, inconspicuous penis, hidden penis, 
congenital mega-prepuce, trapped penis and webbed penis. 
Important to mention is that in buried penis the penile shaft 
is anatomically normal, presenting adequate size for the age 
of the patient. True buried penis is an uncommon condition 
and corrective surgery, that aims reconfiguration of the 
penile skin and prepuce, is always necessary11 (Figure 5).
Figure 4 -  Buried penis 
Figure 5 - Post-operative aspect of a buried penis, after 
reconfiguration of penile and preputial skin
B) Obesity and “fat over upper pubic area” 
(FOUPA) excess
As the number of infantile obesity increases, a 
crescent number of parents search medical attention 
complaining about the small penis of their sons. Obesity 
among children nowadays reaches approximately 8% in 
the first 5 years of life in Brazil, an increase of 79% when 
compared to 2008.
In these patients, besides the obvious obesity, the 
penis is also concealed within the pubic fat, extruding 
somewhat the penile skin and prepuce, therefore giving 
the appearance of a very small penis (Figure 6 and 7). 
Nevertheless, contrary to buried penis, it is possible to 
normally expose the penis, even if it is covered with an 
excess fat pad and if there is a slight phymosis. As in 
buried penis, the shape and size of the penis is normal 
for the age of the patient, but while buried penis requires 
surgical correction, the main treatment of FOUPA excess 
is weight control with physical and alimentary reeducation 
of the children.
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Figure 6 - Obese child with FOUPA simulating a micropenis
Figure 7 - Obese patient with FOUPA. Note that with compression 
of the prepubic fat the penile measurement is normal
Etiology and diagnostic tests 
The causes of congenital or true micropenis can 
be divided into three major groups: hypogonadotropic 
hypogonadism (pituitary/hypothalamic failure), 
hypergonadotropic hypogonadism (primary testicular 
failure) and idiopathic (associated with a functional 
hypothalamus–pituitary–testicular axis). An isolated 
micropenis seems to occur more commonly with 
gonadotropin deficiency, whereas micropenis associated 
with hypospadias and/or undescended testes is often caused 
by lack of testosterone.
Endocrinologic assessment helps determine at 
what level is the cause of micropenis in the hypothalamic-
pituitary-testicular axis. In addition to the central endocrine 
functions, testicular functions also need to be evaluated. 
Hence, serum testosterone levels are to be measured 
before and after administering exogenous hCG. This test 
is performed by intramuscular administration of hCG in 
a dose of 1000 units for 3 days: testosterone levels below 
300 ng/dL may indicate gonadal dysgenesis. If LH and FSH 
levels are elevated, and there is no increase in testosterone 
levels following administration, testicular insufficiency or 
disgenesis should be considered. In addition, measuring 
17 hydroxyprogesterone, dehydroepiandrosterone, 
and androstenedione levels before or after the hCG 
stimulation test can reveal enzyme defects that play a role 
in testosterone synthesis12.
Clinical treatment
Treatment of micropenis aims the increase of penile 
size sufficient for the patient to have an appropriate body 
image, normal sexual function, and standing micturition6. 
Treatment is based on testosterone supplementation 
administered for a short period to evaluate penile response. 
There is no consensus on the dose, method of administration 
or duration of testosterone therapy for micropenis13. 
Hatipoglu et al.12 suggested that administration could 
be by intramuscular injection or topical application. 
In order to observe initial progress, four doses of 25 
mg of testosterone cypionate or enanthate in oil can be 
administered intramuscularly once every 3 weeks for 3 
months. Topical treatment is also employed. Arisaka et 
al.14 demonstrated increase in penile lengths in 50 infants 
and children aged between 5 months and 8 years, by 
administering 5% testosterone cream topically for 30 days. 
Testosterone absorbed transdermally was also shown to 
stimulate growth hormone (GH) secretion from the pituitary 
gland and promote bone growth by increasing insulin-like 
growth factor-1 production. Therefore, long-term dermal 
application of testosterone can also promote skeletal 
growth, as well as penile growth. Topical testosterone can 
be applied both directly at the penile skin or at internal 
thighs if any reaction occurs during the course of treatment.
Topical Dihydrotestosterone (DHT) is an alternative 
topical treatment. The enzyme 5α-reductase catalyzes the 
formation of DHT from testosterone in certain tissues 
including the prostate gland, seminal vesicle, epididymus, 
skin, hair follicle, liver, and brain. Relative to testosterone, 
DHT is considerably more potent as an agonist of the 
androgen receptor (AR). In prepubertal patients with 
androgen insensitivity, topical application of DHT gel to the 
periscrotal region 3 times daily for a total of 5 weeks has 
been shown to increase serum DHT levels12. This treatment 
can provide penile length improvement in patients who did 
not respond to topical testosterone.
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RESULTS 
Usually a 100% fold or 3.5 cm increase in penile 
length is considered a good response. Repeat testosterone 
application or DHT gel can be used in cases of non-
satisfactory penile size increase. Clinical studies have 
shown that testosterone treatment has positive effects on 
penile growth during infancy. However, these studies do 
not show whether this growth continues during adolescence 
and adulthood and a decrease of penile size gain can be 
observed in some patients late after the treatment. 
Adverse reactions
Side effects are minimal. Topical or systemic 
testosterone treatment may cause temporary acceleration in 
growth rate and advance of bone age. Cutaneous reactions 
due to topic testosterone application were related. Changes 
in local application (i.e. inner thigh) may be required. 
Long-term follow-up
The major problem regarding the management of 
micropenis is the lack of knowledge in term of long-term 
outcome. A number of studies15,16,17 showed that patients 
with micropenis reported normal male gender identity, 
good quality erections and sexual intercourse, even if 
always concerned with their genital appearance. Overall, 
it may safely be said that evidence points to normal gender 
identity and normal sexual function even in patients with 
failed treatment. 
Surgical treatment
If endocrine treatment does not accomplish a 
satisfactory result, surgical therapy can offer an alternative 
in the management of micropenis. A simple procedure 
involves the elongation of the penis, despite the fact that 
it doesn´t really improve the penile size. This technique 
aims to extend the pendular portion of penis, therefore 
improving the perception of penile size, by sectioning 
the suspensory ligament. Aditional manouvers, such as 
suprapubic lipectomy and partial detachment of the crura 
from the pubic rami may further improve the cosmetic 
result. Satisfaction rates range from 30-65%20. Important 
to note is that this elongation procedures are indicated to 
be performed only after puberty and after failed hormonal 
therapies. Corporal augmentation procedures have also 
been described in the setting of  micropenis, with acceptable 
short term results, although no long-term data exist20.
Other surgical options for a very small sized penis 
that failed hormonal treatment include neophalloplasy, 
with techniques that vary from osteocutaneous fibula flap, 
free scapular or forearm flaps, suprapubic abdominal wall 
flap and vertical rectus abdomnis flap. These options are 
extremely challenging, with high complications rates even 
in most experienced hands. Functional results, namely 
micturition and sexual activity of neophallus are variable: 
urethral strictures are often observed18 and sexual activity 
depends on the secondary successful implant of a penile 
prosthesis19. 
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